Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases

Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.Professor Sukhbir Singh has a PhD in Pharmaceutical Science and experience of more than 15 years in academia and research. He has 170 publications in various National/International journal of repute, 8 books, 12 books chapter and filed 19 patents to his credit. He has presented/published 40 review/research abstracts in various National/International conferences. His areas of interest in research are nanotechnology/liposome/niosomes/SEDDS based formulation development and solubility enhancement of BCS class II drugs. He has expertise in operation of various statistical analysis toolsDr. Neelam Sharma, PhD in Pharmaceutical Science has experience of more than 13 years in academics and research. She is highly self-determined and organized pharmaceutical research professional. She has 140 publications in various National/International journal of repute, h-index 12 and i 10-index 20, 08 books, 12 books chapter and filed 19 patents to his credit. She has presented/published 35 review/research abstracts in various National/International conferences. She has completed 4 consultancy projects on herbal/homeopathic formulation. She and her team received IEDC, Govt of India, prototyping grant of Rs 2.5 lacs for project related to management of ARDS in COVID, held at Chitkara University, Punjab in 2020 and project has been completed in 2022. She has guided 1 PhD students and 20 M. Pharmacy students and 6 Ph.D students are pursuing PhD under her guidance.

• 1. Understanding the role of angiogenesis, inflammation and oxidative stress in diabetes mellitus: insights into the past, present and future trends2. Targeting angiogenesis, inflammation, and oxidative stress in obesity3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment5. Inflammatory bowel diseases (IBDs)6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer’s siseases11. Advancement in herbal drugs for the treatment of Parkinson’s disease12. Targeting angiogenesis, inflammation, and oxidative stress in depression13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives